Document Detail

Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma.
MedLine Citation:
PMID:  23896244     Owner:  NLM     Status:  In-Data-Review    
Nontherapeutic celiotomy for pancreatic adenocarcinoma is detrimental to patients by delaying medical treatment as a result of unnecessarily incurred postoperative recovery time. This study was undertaken to evaluate whether surgeon volume of pancreaticoduodenectomy for pancreatic adenocarcinoma impacted the incidence of nontherapeutic celiotomy. All patients undergoing an intended pancreaticoduodenectomy for pancreatic adenocarcinoma were evaluated from 2003 to 2012. Survival was calculated using Kaplan-Meier analysis. The association between surgeon volume of pancreaticoduodenectomy and occurrence of nontherapeutic celiotomy was assessed using Fisher's exact test. Median data are presented. Eight surgeons undertook 443 intended pancreaticoduodenectomies for patients with pancreatic adenocarcinoma; 329 (74%) patients underwent pancreaticoduodenectomy, whereas 114 (26%) patients underwent nontherapeutic celiotomies. Two surgeons undertook 85 per cent of operations. Surgeon volume did not impact the incidence of nontherapeutic celiotomies (P = 0.26). Seventy-seven (68%) patients had metastatic disease at the time of the operation, whereas 37 (32%) patients had locally advanced unresectable disease. These patients had survivals of 5.0 and 6.0 months, respectively (P = 0.77). A high proportion of patients-one in four-undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma will ultimately undergo a nontherapeutic celiotomy. Surgeon volume of pancreaticoduodenectomy for pancreatic adenocarcinoma does not lessen the incidence of nontherapeutic celiotomies. Preoperative prediction of patients with imaging-occult metastatic or locally advanced disease remains a challenge, even for high-volume surgeons. Attempts to create algorithms for patients with high risk of imaging-occult metastatic or locally advanced disease to undergo staging laparoscopy and/or positron emission tomography scanning may decrease the burden of patients undergoing nontherapeutic celiotomies.
Paul Toomey; Christopher Childs; Kenneth Luberice; Sharona Ross; Alexander Rosemurgy
Related Documents :
24838004 - The epidemic of inadequate bi-ventricular pacing in patients with persistent or permane...
18438814 - The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of pa...
23095714 - Different pattern of clinical deficits in stroke mimics treated with intravenous thromb...
23377814 - The effects of losartan on oxidative stress and inflammation in non-diabetic patients u...
1152504 - The hemostatic mechanism after open-heart surgery. i. studies on plasma coagulation fac...
12133044 - Exteroceptive suppression patterns of masseter and temporalis muscles in central and pe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American surgeon     Volume:  79     ISSN:  1555-9823     ISO Abbreviation:  Am Surg     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370522     Medline TA:  Am Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  781-5     Citation Subset:  IM    
The Southeastern Center for Digestive Disorders & Pancreatic Cancer, Advanced Minimally Invasive & Robotic Surgery, Florida Hospital Tampa, Tampa, Florida, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Measuring the Impact of Multidisciplinary Care on Quality for Pancreatic Surgery: Transition to a Fo...
Next Document:  Postoperative Quality of Life after Open Transinguinal Preperitoneal Inguinal Hernia Repair Using Me...